Thrombin mediated cytotoxicity during cerebral ischemia
Thrombin mediated cytotoxicity during cerebral ischemia
批准号:
9927678
负责人:
Patrick D Lyden
金额:
$11.02万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-15 至 2020-09-12
关键词:
AddressAgonistAnimalsArgatrobanAstrocytesAttentionAwardBiological AssayBrainCaringCell CommunicationCellsCerebral IschemiaCerebrumClinical TrialsCollaborationsDataDoseElementsEndothelial CellsF2R geneFactor XaFundingGenesInjuryIschemiaKnockout MiceLentivirus VectorLiteratureMass Spectrum AnalysisMediatingMessenger RNAMicrofluidicsModelingMonitorMusNeuronal InjuryNeuronsOligodendrogliaPAR-1 ReceptorPeptide HydrolasesPeptidesPericytesPhasePlayProcessPropertyProteinsProteomicsProthrombinPublishingReactionResearchResearch PersonnelRoleSignal TransductionStimulusStrokeTamoxifenTechniquesTestingThrombinTrypsinWorkbasebehavioral outcomebrain cellconditional knockoutconditioningcytotoxicityexperimental studyimprovedin vivoinhibitor/antagonistinnovationinsightneuroprotectionneurovascular unitnovelparacrinepreconditioningreceptorresponseresponse to brain injuryresponse to injurystroke patienttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We propose a novel and exciting hypothesis—based on literature and our own pilot data—that
neuronal injury stimulates astrocyte activation via thrombin and its receptor PAR-1, and the
resulting astrocyte response to injury yields transmissible paracrine protection of neurons.
Together, neurons, astroctyes, endothelial cells, pericytes, and oligodendroglia comprise the
neurovascular unit, or NVU. Data generated from the several aims will yield insights into the
mechanism for the well-documented phenomenon of pre-conditioning; will provide considerable
insights into the mechanisms of differential vulnerability to cerebral injury; and would likely yield
treatment options for stroke patients. To accomplish the aims, we are creating novel conditional
knock-out mice that will provide research tools to the broader research field. The previous
award, R01 NS075930, covered 8/15/2011 to 03/31/2015 and involved 4 aims. All proposed
work has been completed and published or under review. The data from our prior award has
already influenced stroke care significantly, in the form of two funded clinical trials. However, our
prior data could not fully explain the known differences among the elements of the NVU,
specifically, that astrocytes and endothelial cells tolerate ischemia better than neurons. What is
the mechanism of thrombin-mediated pre-conditioning, and can we relate that mechanism to
other forms of pre- and peri-conditioning? Why does the brain contain prothrombin mRNA and
protein and what purpose could be served by thrombin activation in brain? Could we derive
insights about the response of the brain to injury, and specifically explore the cell-subtype
interactions during injury among astrocytes, neurons, pericytes, oligodendroglia, and endothelial
cells? To answer these questions, and to address the central hypothesis of the present award
application, we added significant new models to our repertoire, and generated pilot data
speaking to the feasibility and novelty of the proposed new specific aims.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The NIH SPAN Coordinating Center
-
批准号:10591751
-
项目类别:
-
资助金额:$100.85万
-
财政年份:2023
-
负责人:Patrick D Lyden
-
依托单位:
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
-
批准号:10305528
-
项目类别:
-
资助金额:$398.01万
-
财政年份:2022
-
负责人:Patrick D Lyden
-
依托单位:
The NIH SPAN Coordinating Center
-
批准号:10074917
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2020
-
负责人:Patrick D Lyden
-
依托单位:
The NIH SPAN Coordinating Center
-
批准号:10339173
-
项目类别:
-
资助金额:$65.58万
-
财政年份:2019
-
负责人:Patrick D Lyden
-
依托单位:
The NIH SPAN Coordinating Center
-
批准号:10224355
-
项目类别:
-
资助金额:$78.29万
-
财政年份:2019
-
负责人:Patrick D Lyden
-
依托单位:
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke
-
批准号:9095477
-
项目类别:
-
资助金额:$198.86万
-
财政年份:2014
-
负责人:Patrick D Lyden
-
依托单位:
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke
-
批准号:8760276
-
项目类别:
-
资助金额:$243.98万
-
财政年份:2014
-
负责人:Patrick D Lyden
-
依托单位:
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke
-
批准号:8880302
-
项目类别:
-
资助金额:$217.67万
-
财政年份:2014
-
负责人:Patrick D Lyden
-
依托单位:
Thrombin mediated cytotoxicity during cerebral ischemia
-
批准号:10327599
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2011
-
负责人:Patrick D Lyden
-
依托单位:
Thrombin Mediated Cytotoxicity during Cerebral Ischemia
-
批准号:8318076
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2011
-
负责人:Patrick D Lyden
-
依托单位:
Thrombin Mediated Cytotoxicity during Cerebral Ischemia
-
批准号:8448649
-
项目类别:
-
资助金额:$35.25万
-
财政年份:2011
-
负责人:Patrick D Lyden
-
依托单位:
Thrombin Mediated Cytotoxicity during Cerebral Ischemia
-
批准号:8250245
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2011
-
负责人:Patrick D Lyden
-
依托单位:
Quantitation of Early Vascular Leakage after Stroke
-
批准号:6961558
-
项目类别:
-
资助金额:$20.04万
-
财政年份:2005
-
负责人:Patrick D Lyden
-
依托单位:
Quantitation of Early Vascular Leakage after Stroke
-
批准号:7140319
-
项目类别:
-
资助金额:$16.3万
-
财政年份:2005
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy
-
批准号:6948413
-
项目类别:
-
资助金额:$6.3万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy
-
批准号:7166130
-
项目类别:
-
资助金额:$6.62万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Hypothermia
-
批准号:6751836
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy
-
批准号:7247999
-
项目类别:
-
资助金额:$128.85万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy (P50)
-
批准号:7629859
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy
-
批准号:6749550
-
项目类别:
-
资助金额:$119.42万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: